Please login to the form below

Not currently logged in
Email:
Password:

Mimpara

This page shows the latest Mimpara news and features for those working in and with pharma, biotech and healthcare.

NICE set to back Parsabiv for kidney disease complication

NICE set to back Parsabiv for kidney disease complication

be treated with Amgen's older drug Sensipar/Mimpara (cinacalcet) - and provided Amgen supplies the drug at an agreed discount.

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • PAN and DJM win prestigious Global Award

    PAN and DJM win prestigious Global Award. Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their animation of Mimpara Man’ for Amgen. ... Creative agency PAN and sister digital agency DJM Solutions

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics